With the global aging population and the high incidence of respiratory diseases such as chronic obstructive pulmonary disease (COPD) and asthma, the demand for atomizers, as key medical devices for treating these diseases, has been steadily rising. This paper analyzes the global atomizer market through data analysis and statistical methods, focusing on market size, growth trends, product segmentation, user demand, and price acceptance. The results show that the global atomizer market has a compound annual growth rate (CAGR) of 6.2% from 2020 to 2030, with the market size expected to reach 1.45 billion USD by 2030; Monte Carlo simulation indicates a potential range of 1.2–1.8 billion USD, reflecting significant growth potential. In terms of product types, pneumatic atomizers currently dominate with a 55–60% market share, but mesh atomizers are expected to grow to over 25% due to technological advancements. User group analysis reveals that patients aged 31–45 and 18–30 (high-risk groups for respiratory diseases) are the main users, with patients prioritizing safety and ease of use, while medical staff focus on performance and reliability. Price acceptance varies: patients prefer economical products (300–500 yuan for hosts, 10–20 yuan for consumables), while medical staff are willing to pay more for high-performance devices. This study provides insights for enterprises in market positioning, product development, and pricing strategies.